/
Why don't some CanRisk Tool results match results obtained with earlier versions of the CanRisk Tool or the BOADICEA Web Application?
Why don't some CanRisk Tool results match results obtained with earlier versions of the CanRisk Tool or the BOADICEA Web Application?
The CanRisk Tool uses two risk models to estimate breast and ovarian cancer risks: the BOADICEA Model and the Ovarian Cancer Model. These models are periodically updated in order to: (i) incorporate additional information in risk calculations (e.g. new genes and risk factors); and (ii) ensure that they are based on the most up-to-date epidemiological data. For example, when we have released previous versions of the software in the past, we have updated: population cancer incidence rates, relative risks, mutation search sensitivities and pathology distributions for mutation carriers. These updates ensure that the risks predicted by the tool are as reliable as possible based on the latest evidence. However, this also explains why some results obtained with the latest version of the tool differ from those obtained using previous versions of the software.
, multiple selections available,
Related content
Risk Calculations
Risk Calculations
Read with this
Why has the CanRisk Tool calculated mutation carrier probabilities but not cancer risks?
Why has the CanRisk Tool calculated mutation carrier probabilities but not cancer risks?
More like this
Why do BRCA mutation carrier probabilities sometimes increase abruptly when I increase an age at breast cancer diagnosis from 19 to 20 years in my input pedigree?
Why do BRCA mutation carrier probabilities sometimes increase abruptly when I increase an age at breast cancer diagnosis from 19 to 20 years in my input pedigree?
More like this
What does the CanRisk Tool do?
What does the CanRisk Tool do?
More like this
How do I enter Polygenic Risk Scores manually using the CanRisk Tool?”
How do I enter Polygenic Risk Scores manually using the CanRisk Tool?”
More like this
How are rare genetic pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 , RAD51C, RAD51D, and BRIP1 used in the CanRisk Tool?
How are rare genetic pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 , RAD51C, RAD51D, and BRIP1 used in the CanRisk Tool?
More like this